Company profile
Homepage - Orchard Therapeutics
Orchard Therapeutics (Europe) Limited is a UK company with status active founded in 2015.
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
CS01 | Transaction MzQ1NTgwMTkwNGFkaXF6a2N4
Published 20 Feb 2025 09:57
PSC06 | Transaction MzQ1NTgwMTQzNWFkaXF6a2N4
Published 20 Feb 2025 02:45
Last accounts made up date
AA | Transaction MzQzNzk3MjgyMmFkaXF6a2N4 | Paper/PDF filed
Published 08 Oct 2024 06:24
Company registered at Companies House
Ex vivo bone marrow gene therapy company
Orchard Therapeutics is a biotechnology company incorporated in September 2015 and dedicated to bringing transformative gene therapies to patients with serious and life-threatening orphan diseases Our programmes will use the potential of ex-vivo autologous haematopoietic stem cell gene therapy to restore normal gene function in severe and life-threatening inherited disorders We work in partnership with the world's leading research centres to harness the life-giving potential of gene therapy Our mission is to translate results from pre-clinical and early clinical research into commercially approved gene therapies for patients around the world
none so far but intention to take gene therapy developments to licensed medicines
Currently have one program in clinical development aiming to submit for marketing approval 2018/19
1 Mar 2020 to 31 Mar 2021
Many advanced therapies involve manual cell culture steps at manufacture. Cytera will work with Orchard Therapeutics to automate some of these manual cell culture steps which are relevant for Orchard, as well as others in the industry
